DK85490D0 - Krystallinsk (5r,6s)-2-carbamoyloxymethyl-6-((1r)-hydroxyethyl)-2-penemcarboxylsyre og dens farmaceutiske formulering - Google Patents

Krystallinsk (5r,6s)-2-carbamoyloxymethyl-6-((1r)-hydroxyethyl)-2-penemcarboxylsyre og dens farmaceutiske formulering

Info

Publication number
DK85490D0
DK85490D0 DK085490A DK85490A DK85490D0 DK 85490 D0 DK85490 D0 DK 85490D0 DK 085490 A DK085490 A DK 085490A DK 85490 A DK85490 A DK 85490A DK 85490 D0 DK85490 D0 DK 85490D0
Authority
DK
Denmark
Prior art keywords
carbamoyloxymethyl
hydroxyethyl
crystallic
pharmaceutical formulation
acid
Prior art date
Application number
DK085490A
Other languages
English (en)
Other versions
DK85490A (da
DK171235B1 (da
Inventor
Carlo Battistini
Roberto Bianchini
Stefano Del Nero
Pierluigi Griggi
Sergio Vioglio
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of DK85490D0 publication Critical patent/DK85490D0/da
Publication of DK85490A publication Critical patent/DK85490A/da
Application granted granted Critical
Publication of DK171235B1 publication Critical patent/DK171235B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/86—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK085490A 1988-08-08 1990-04-05 Krystallinsk (5R,6S)-2-carbamoyloxymethyl-6-[(IR)-hydroxyethyl]-2-penemcarboxylsyre, fremgangsmåde til fremstilling heraf, samt farmaceutisk præparat indeholdende syren DK171235B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8818789 1988-08-08
GB888818789A GB8818789D0 (en) 1988-08-08 1988-08-08 Crystalline(5r 6s)-2-carbamoyloxymethyl-6-((1r)-hydroxyethyl)-2-penem-carboxylic acid & pharmaceutical formulation
EP8900924 1989-08-04
PCT/EP1989/000924 WO1990001484A1 (en) 1988-08-08 1989-08-04 Crystalline (5r,6s)-2-carbamoyloxymethyl-6-[(1r)-hydroxyethyl]-2-penem-carboxylic acid and its pharmaceutical formulation

Publications (3)

Publication Number Publication Date
DK85490D0 true DK85490D0 (da) 1990-04-05
DK85490A DK85490A (da) 1990-06-07
DK171235B1 DK171235B1 (da) 1996-08-05

Family

ID=10641768

Family Applications (1)

Application Number Title Priority Date Filing Date
DK085490A DK171235B1 (da) 1988-08-08 1990-04-05 Krystallinsk (5R,6S)-2-carbamoyloxymethyl-6-[(IR)-hydroxyethyl]-2-penemcarboxylsyre, fremgangsmåde til fremstilling heraf, samt farmaceutisk præparat indeholdende syren

Country Status (21)

Country Link
US (1) US5302588A (da)
EP (1) EP0407478B1 (da)
JP (1) JP2954956B2 (da)
KR (1) KR900701799A (da)
AT (1) ATE112777T1 (da)
AU (1) AU626576B2 (da)
CA (1) CA1339422C (da)
DE (1) DE68918849T2 (da)
DK (1) DK171235B1 (da)
ES (1) ES2015770A6 (da)
FI (1) FI95575C (da)
GB (1) GB8818789D0 (da)
GR (1) GR1002251B (da)
HU (1) HU205934B (da)
IE (1) IE68447B1 (da)
IL (1) IL91216A (da)
NZ (1) NZ230196A (da)
PT (1) PT91383B (da)
RU (1) RU2074858C1 (da)
WO (1) WO1990001484A1 (da)
ZA (1) ZA895966B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5492903A (en) * 1990-06-19 1996-02-20 Takeda Chemical Industries Ltd. Crystalline esters of (+)-(5R, 6S)-6-[(R)-1-hydroxyethyl]-3-(3-pyridyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]he
US20090275746A1 (en) * 2006-07-28 2009-11-05 Hetero Drugs Limited Solid faropenem free acid
KR20160109904A (ko) * 2015-03-13 2016-09-21 주식회사 대웅제약 결정형 도리페넴의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482565A (en) * 1980-02-22 1984-11-13 Farmitalia Carlo Erba S.P.A. β-Lactam-containing antibacterial agents and β-lactamase inhibitors
SU1389680A3 (ru) * 1981-12-11 1988-04-15 Фармиталия Карло Эрба С.П.А. (Фирма) Способ получени оптически активных пенемов или их солей с щелочными металлами
US4761408A (en) * 1984-11-02 1988-08-02 Ciba-Geigy Corporation Crystalline aminomethyl compound
US4634556A (en) * 1985-05-10 1987-01-06 Schering Corporation Crystalline sodium (5R, 6S, 8R)-6-(1-hydroxyethyl)-2-(2-carbamoyloxyethylthio)-penem-3-carboxylate and process for making same
PT84767B (en) * 1986-04-29 1989-06-09 Ciba Geigy Ag Process for preparing a crystalline (5r.6s)-2-aminomethyl-6-](1r)-1-hydroxyethyl"-2-penem-3-carboxylic acid hydrate
GB8915392D0 (en) * 1989-07-05 1989-08-23 Erba Carlo Spa Process for penems

Also Published As

Publication number Publication date
FI901710A0 (fi) 1990-04-04
IE892528L (en) 1990-02-08
KR900701799A (ko) 1990-12-04
IL91216A (en) 1994-10-21
ES2015770A6 (es) 1990-09-01
GR1002251B (en) 1996-04-23
US5302588A (en) 1994-04-12
DK85490A (da) 1990-06-07
EP0407478B1 (en) 1994-10-12
ZA895966B (en) 1990-06-27
RU2074858C1 (ru) 1997-03-10
HUT56571A (en) 1991-09-30
NZ230196A (en) 1990-09-26
FI95575B (fi) 1995-11-15
PT91383A (pt) 1990-03-08
IL91216A0 (en) 1990-03-19
GB8818789D0 (en) 1988-09-07
GR890100493A (el) 1990-08-22
JPH03500781A (ja) 1991-02-21
PT91383B (pt) 1995-05-31
DE68918849T2 (de) 1995-02-23
FI95575C (fi) 1996-02-26
JP2954956B2 (ja) 1999-09-27
WO1990001484A1 (en) 1990-02-22
HU205934B (en) 1992-07-28
IE68447B1 (en) 1996-06-26
CA1339422C (en) 1997-09-02
ATE112777T1 (de) 1994-10-15
AU626576B2 (en) 1992-08-06
EP0407478A1 (en) 1991-01-16
DE68918849D1 (de) 1994-11-17
AU4049089A (en) 1990-03-05
HU894594D0 (en) 1991-07-29
DK171235B1 (da) 1996-08-05

Similar Documents

Publication Publication Date Title
RU95114376A (ru) Нитроэфиры, обладающие фармакологической активностью, и способ их получения
KR960705815A (ko) 신규한 피라진 카복스아미드 유도체, 이의 제조방법 및 약제에 있어서의 이의 용도(Novel pyrazine carboxamide derivatives, their production and their use in medicaments)
FI98067C (fi) Uusia alkyleenidiammoniumdiklavulanaattijohdannaisia, menetelmä niidenvalmistamiseksi samoin kuin niiden käyttö kalvulaanihapon puhdistamiseksi
SE9402595L (sv) Förfarande för kristallisation av iopamidol
FI881644A (fi) Framstaellning av (1r,5s,6s)-2 -substituerade tio-6-/(r)-1-hydroxietyl/-1-metyl-karbapenem-2 -karboxylsyraderivat.
DK85490D0 (da) Krystallinsk (5r,6s)-2-carbamoyloxymethyl-6-((1r)-hydroxyethyl)-2-penemcarboxylsyre og dens farmaceutiske formulering
DK505485D0 (da) Krystallinsk (5r,6s)-2-aminomethyl-6-((1r)-1-hydroxyethyl)-2-penem-3-carboxylsyre samt dens fremstilling og anvendelse
DE3463050D1 (en) Novel penem compounds, pharmaceutical compositions containing them, processes for their preparation
NO165399C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (5r,6s)-6-((r)-1-hydroksyetyl)-penem-derivater.
ATE88706T1 (de) In 2-stellung substituierte (1r,5s,6s)-2-thio-6((r)-1-hydroxyethyl>-1-methyl-carbapenem-carbonsaeure-derivate.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed